ORTHOVISC HIGH MOLECULAR WEIGHT HYALURONAN

Acid, Hyaluronic, Intraarticular

FDA Premarket Approval P030019

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the orthovisc high molecular weight hyaluronan. The device is indicated fo the treatment of pain in osteoarthritis (oa) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and to simple analgesics (e. G. , acetaminophen).

DeviceORTHOVISC HIGH MOLECULAR WEIGHT HYALURONAN
Classification NameAcid, Hyaluronic, Intraarticular
Generic NameAcid, Hyaluronic, Intraarticular
ApplicantAnika Therapeutics, Inc.
Date Received2003-05-30
Decision Date2004-02-04
Notice Date2006-08-24
PMAP030019
SupplementS
Product CodeMOZ
Docket Number06M-0339
Advisory CommitteeOrthopedic
Expedited ReviewNo
Combination Product No
Applicant Address Anika Therapeutics, Inc. 32 Wiggins Avenue bedford, MA 01730
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P030019Original Filing
S027 2022-10-12 30-day Notice
S026 2020-12-30 135 Review Track For 30-day Notice
S025 2020-11-09 30-day Notice
S024
S023 2016-02-10 Special (immediate Track)
S022 2014-12-24 135 Review Track For 30-day Notice
S021 2014-06-25 30-day Notice
S020 2014-06-10 30-day Notice
S019 2014-05-15 30-day Notice
S018 2011-08-24 135 Review Track For 30-day Notice
S017 2010-11-03 135 Review Track For 30-day Notice
S016
S015 2010-06-09 30-day Notice
S014 2009-06-16 Normal 180 Day Track No User Fee
S013 2006-07-24 135 Review Track For 30-day Notice
S012 2006-08-09 Normal 180 Day Track
S011
S010 2006-07-10 30-day Notice
S009 2006-04-28 Normal 180 Day Track
S008 2006-01-03 30-day Notice
S007
S006 2004-07-01 Normal 180 Day Track
S005 2004-06-17 30-day Notice
S004 2004-05-07 30-day Notice
S003 2004-03-16 30-day Notice
S002
S001 2004-02-27 135 Review Track For 30-day Notice

NIH GUDID Devices

Device IDPMASupp
05060548950026 P030019 000
08437027710025 P030019 000
05060459970038 P030019 022
00817337000111 P030019 026

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.